PARANEOPLASTIC CEREBELLAR DEGENERATION IN A PATIENT WITH CHEMOTHERAPY-RESPONSIVE OVARIAN-CANCER

被引:6
|
作者
MCCRYSTAL, M
ANDERSON, NE
JONES, RW
EVANS, BD
机构
[1] AUCKLAND HOSP,DEPT CLIN ONCOL,AUCKLAND,NEW ZEALAND
[2] AUCKLAND HOSP,DEPT NEUROL,AUCKLAND,NEW ZEALAND
[3] NATL WOMENS HOSP,AUCKLAND,NEW ZEALAND
[4] GREEN LANE HOSP,AUCKLAND 3,NEW ZEALAND
关键词
OVARIAN CANCER; PARANEOPLASTIC CEREBELLAR DEGENERATION;
D O I
10.1046/j.1525-1438.1995.05050396.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 54-year-old female with small volume residual stage III ovarian cancer had received two courses of carboplatin chemotherapy with obvious response, when she developed rapidly progressive neurological symptoms. Over a period of 48 h, an incapacitating syndrome of ataxia, nystagmus and dysarthria evolved. Central nervous system metastases were excluded by computed tomography scanning and cerebrospinal fluid cytology. Anti-Purkinje cell antibodies ('anti-Yo') detected in the serum confirmed the diagnosis of paraneoplastic cerebellar degeneration. Isolated reports have suggested that the clinical course of this condition can be ameliorated with high dose steroids and plasmapheresis. However, in this case the very early introduction of both these did not bring about any improvement in the patient's symptoms. She remained severely incapacitated and unable to care for herself for the remaining 15 months of her life. The patient died of progressive ovarian cancer that had become clinically evident 10 months after the onset of neurological symptoms. This case illustrates many of the classical features of this rare condition, and the world literature is reviewed.
引用
收藏
页码:396 / 399
页数:4
相关论文
共 50 条
  • [41] CHEMOTHERAPY OF EPITHELIAL OVARIAN-CANCER
    ATKINSON, RJ
    IRISH JOURNAL OF MEDICAL SCIENCE, 1985, 154 (11) : 441 - 441
  • [42] CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER
    RODENBURG, CJ
    CLETON, FJ
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 107 (02) : 99 - 105
  • [43] CHEMOTHERAPY OF OVARIAN-CANCER - AN UPDATE
    ILANCHERAN, A
    SINGH, P
    RATNAM, SS
    SINGAPORE JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1986, 17 (03) : 152 - 158
  • [44] STANDARD OF CHEMOTHERAPY IN OVARIAN-CANCER
    PFLEIDERER, A
    MEERPOHL, HG
    CHIRURG, 1994, 65 (01): : 18 - 22
  • [45] CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER
    STEWART, LA
    PARMAR, MKB
    GUTHRIE, D
    WILLIAMS, CJ
    BRITISH MEDICAL JOURNAL, 1992, 304 (6819): : 119 - 119
  • [46] Paraneoplastic cerebellar degeneration in platinum-responsive endometrial cancer: A case report and review of literature
    Liontos, Michalis
    Fiste, Oraianthi
    Drakopoulou, Danai
    Thomakos, Nikolaos
    Goula, Kalliroi
    Zagouri, Flora
    Anagnostouli, Maria
    Dimopoulos, Meletios-Athanasios
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [47] Paraneoplastic cerebellar degeneration associated with ovarian cancer:: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma
    Bartos, A
    Stourac, P
    Rusina, R
    Sejdová, M
    Velenská, Z
    NERVENARZT, 2002, 73 (10): : 995 - 998
  • [48] Marantic endocarditis (NBTE) with systemic emboli and paraneoplastic cerebellar degeneration: uncommon presentation of ovarian cancer
    Veerpal Singh
    Ishfaq Bhat
    Kathleen Havlin
    Journal of Neuro-Oncology, 2007, 83 : 81 - 83
  • [49] Marantic endocarditis (NBTE) with systemic emboli and paraneoplastic cerebellar degeneration: uncommon presentation of ovarian cancer
    Singh, Veerpal
    Bhat, Ishfaq
    Havlin, Kathleen
    JOURNAL OF NEURO-ONCOLOGY, 2007, 83 (01) : 81 - 83
  • [50] A quaint masquerader of breast cancer: Paraneoplastic cerebellar degeneration
    Chacko, Steffi
    Joseph, Rona
    Manoharan, Anoop Thattungal
    Venugopal, M.
    NEUROLOGY INDIA, 2019, 67 (03) : 892 - 894